Israel - English - Ministry of Health

perrigo israel agencies ltd - vinflunine ditartrate - concentrate for solution for infusion - vinflunine ditartrate 25 mg/ml - vinflunine - vinflunine - javlor is indicated in monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinium-containing regimen. efficacy and safety of vinflunine have not been studied in patients with performance status ≥2.

Australia - English - Department of Health (Therapeutic Goods Administration)

pierre fabre australia pty ltd - vinflunine ditartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pierre fabre australia pty ltd - vinflunine ditartrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

pierre fabre australia pty ltd - vinflunine ditartrate -

European Union - English - EMA (European Medicines Agency)

pierre fabre medicament - vinflunine - carcinoma, transitional cell; urologic neoplasms - antineoplastic agents - javlor is indicated in monotherapy for the treatment of adult patients with advanced or metastatic transitional-cell carcinoma of the urothelial tract after failure of a prior platinum-containing regimen.efficacy and safety of vinflunine have not been studied in patients with performance status ≥ 2.

Singapore - English - HSA (Health Sciences Authority)

orient europharma pte ltd - vinflunine ditartrate 34.175 mg/ml eqv vinflunine - infusion, solution concentrate - 25mg/ml - vinflunine ditartrate 34.175 mg/ml eqv vinflunine 25mg/ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pierre fabre ltd - vinflunine ditartrate - solution for infusion - 25mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pierre fabre ltd - vinflunine ditartrate - solution for infusion - 25mg/1ml